Clinical Trial Update: Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study [NA]

View source ↗

Summary

A completed clinical trial update on the Promote Q CRT-D and Quartet LV lead study sponsored by Abbott Medical Devices.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D)
• Quartet Left Ventricular Heart Lead

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | NA | Status: COMPLETED | Results posted: 2019-02-27